Vanguard Global Advisers’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Sell
16,918
-3,236
-16% -$89K ﹤0.01% 2229
2026
Q2
$644K Buy
20,154
+4,674
+30% +$155K ﹤0.01% 1985
2026
Q1
$593K Buy
+15,480
New +$501K ﹤0.01% 1959

Other funds holding TYRA

Vanguard Global Advisers's TYRA Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Tyra Biosciences (TYRA) stake by 16% in Q3 2026, selling an estimated $89K and leaving 16,918 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

Vanguard Global Advisers first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $644K in Q2 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Vanguard Global Advisers held 16,918 shares of Tyra Biosciences worth $370K as of Q3 2026.
  • Vanguard Global Advisers sold 3,236 Tyra Biosciences shares in Q3 2026, an estimated $89K.
  • Tyra Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2229 holding.
  • Vanguard Global Advisers first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Tyra Biosciences position peaked at $644K in Q2 2026.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.